# Cell therapy for left ventricular dysfunction or heart failure
A data-only living systematic review

**Clinical summary:** This meta-analysis suggests that clinical intervention *is* effective in preserving or increasing the ejection fraction. However, there is 'substantial' heterogeneity of study results. The heterogeneity is partly explained by more recent studies showing less favorable results.

[Keep current with this topic](Keep-up.md)

**Methods overview:** This repository is an [openMetaAnalysis](https://openmetaanalysis.github.io/) that updates a previously published meta-analysis.(1) Newer studies included are listed in the references below. Rationale for newer trials excluded may be listed at the end of the references. 

This repository is a limited review and contains outcomes data only without PICO and Risk of Bias Tables.  This review does not include a GRADE Profile or Summary of Findings Table.

See [methods](http://openmetaanalysis.github.io/methods.html) for details.

**Results:** Details of the studies included are in the:
* [Forest plots](../../tree/master/forest-plots) ([source data](../../tree/master/data))

The forest plot for the primary outcome is below. Additional [forest plots](../../tree/master/forest-plots) of secondary analyses may be available. 
![Principle results](https://raw.githubusercontent.com/openMetaAnalysis/Cell-therapy-for-left-ventricular-dysfunction/master/forest-plots/Outcome-Primary.png "Principle results")

The metaregression for the primary outcome is below. Additional [metaregression plots](../../tree/master/metaregression) may be available.
![Principle results](https://raw.githubusercontent.com/openMetaAnalysis/Cell-therapy-for-left-ventricular-dysfunction/master/metaregression/Outcome-Primary.png "Principle results - metaregression")

References:
----------------------------------
### Systematic review(s)
####Most recent review(s) at time of last revision of this repository
1. Fisher SA, Doree C, Mathur A, Martin-Rendon E. Meta-Analysis of Cell Therapy Trials for Patients with Heart Failure - An Update. Circ Res. 2015 Jan 28. pii: [CIRCRESAHA.114.304386](http://dx.doi.org/CIRCRESAHA.114.304386). PMID: [25632038](http://pubmed.gov/25632038)<br/>Search date: June, 2014<br/>Number of trials: 31
1. *Nonischemic cardiomyopathy*: Marquis-Gravel G, Stevens LM, Mansour S, Avram R, Noiseux N. Stem cell therapy for the treatment of nonischemic cardiomyopathy: a systematic review of the literature and meta-analysis of randomized controlled trials. Can J Cardiol. 2014 Nov;30(11):1378-84. doi: [10.1016/j.cjca.2014.03.026](http://dx.doi.org/10.1016/j.cjca.2014.03.026). PMID: [25138483](http://pubmed.gov/25138483)
1. Fisher SA, Brunskill SJ, Doree C, Mathur A, Taggart DP, Martin-Rendon E. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst Rev. 2014 Apr 29;4:CD007888. doi:
[10.1002/14651858.CD007888.pub2](http://dx.doi.org/10.1002/14651858.CD007888.pub2). PMID: [24777540](http://pubmed.gov/24777540).<br/>Search date: March, 2013<br/>Number of trials: 23

### Randomized controlled trials
#### New trial(s) *not* included in the most recent review above
1. *Included by converting IQRs to SDs*: Pätilä T, Lehtinen M, Vento A, at al. Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: a prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass. J Heart Lung Transplant. 2014 Jun;33(6):567-74. doi: [10.1016/j.healun.2014.02.009](http://dx.doi.org/10.1016/j.healun.2014.02.009). PMID: [24656645](http://pubmed.gov/24656645)

#### Trials included in the review above
